Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer.

@article{Pruthi2010IdentificationAM,
  title={Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer.},
  author={S Pruthi and Bobbie S. Gostout and Noralane Morey Lindor},
  journal={Mayo Clinic proceedings},
  year={2010},
  volume={85 12},
  pages={
          1111-20
        }
}
Women with a germline BRCA1 or BRCA2 mutation or a hereditary predisposition for breast and ovarian cancer have substantial risk of breast or ovarian cancer relative to the general US population. Health care professionals can be instrumental in identifying women at increased risk through obtaining a comprehensive family history and becoming familiar with family history characteristics associated with hereditary predisposition for breast and ovarian cancer. BRCA carriers and women at very high… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 92 CITATIONS, ESTIMATED 61% COVERAGE

Reducing the risk of breast cancer: A personalized approach.

  • The Journal of family practice
  • 2012
VIEW 10 EXCERPTS
CITES BACKGROUND & METHODS

Novel Docetaxel Formulation (NDLS) in Low Cardiac Reserve Ovarian Cancer

  • 2018
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Diagnosis and Management of Ovarian Cancer.

VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2010
2019

CITATION STATISTICS

  • 4 Highly Influenced Citations

  • Averaged 10 Citations per year from 2017 through 2019